Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial.
Karim QA, Kharsany AB, Frohlich JA, Baxter C, Yende N, Mansoor LE, Mlisana KP, Maarschalk S, Arulappan N, Grobler A, Sibeko S, Omar Z, Gengiah TN, Mlotshwa M, Samsunder N, Karim SS.
Karim QA, et al. Among authors: karim ss.
Trials. 2011 Mar 7;12:67. doi: 10.1186/1745-6215-12-67.
Trials. 2011.
PMID: 21385354
Free PMC article.
Clinical Trial.